+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Sterile Tubing Welder Market Outlook 2030

  • PDF Icon

    Report

  • 220 Pages
  • October 2021
  • Region: Global
  • Research Nester Pvt. Ltd
  • ID: 5475198
Sterile tubing welder is a medical device which is used for welding together two pieces of thermoplastic tubing that contains fluid, usually blood. The global sterile tubing welder market is anticipated to grow with a CAGR of 4.49% during the forecast period, i.e., 2021 - 2030. Factors such as the rising concern for blood disorders worldwide, followed by the increasing prevalence of chronic diseases, and the need for maintaining a sterile and hygienic environment in hospital and clinical laboratories, are anticipated to drive the growth of the market. The market is estimated to garner a revenue of about USD 3463660 Thousand by the end of 2030, up from a revenue of close to USD 2247000.0 Thousand in the year 2020.

The global sterile tubing welder market is segmented by numerous segments, which include segmentation by application, end-user, and by region. The end-user segment is further divided on the basis of hospitals, diagnostic laboratories, blood banks, research organization, and biopharmaceutical companies, out of which, the hospitals segment is anticipated to garner the largest revenue of close to USD 1065090 Thousand by the end of 2030, by growing with a CAGR of 4.24% during the forecast period. Moreover, in the year 2020, the segment registered the largest revenue of around USD 707400 Thousand in the year 2020.

On the basis of geographical analysis, the global sterile tubing welder market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. In the year 2020, the market in North America registered the largest revenue of USD 1116759.0 Thousand. The market in the region is further projected to touch USD 1695833.0 Thousand by the end of 2030.

Some of the prominent industry leaders in the global sterile tubing welder market that are included in our report are Genesis BPS, TERUMO BCT, INC., Wuhan bms Medicaltech Co., Ltd., Sartorius AG, MGA Technologies, Global Life Sciences Solutions USA LLC (Cytiva), Vante Biopharm/Sebra, Pall Corporation, Saint-Gobain Performance Plastics, Sentinel Process Systems Inc., and others.

Table of Contents

1. Market Definition
1.1. Definition
1.2. Market Segmentation
2. Assumptions and Acronyms
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. Executive Summary - Global Sterile Tubing Welder Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities7. Major Roadblocks for the Market Growth8. Regulatory and Standards Landscape9. Industry Risk Analysis
10. Industry Value Chain Analysis
10.1. Raw Material Procurement
10.2. Manufacturers
10.3. Distributors
10.4. End-Users
11. Industry Growth Outlook12. Competitive Positioning
13. Competitive Landscape
13.1. Market Share Analysis, 2020
13.2. Competitive Benchmarking
13.3. Company Profiles
13.3.1. Genesis BPS
13.3.2. TERUMO BCT, INC.
13.3.3. Wuhan bms Medicaltech Co., Ltd.
13.3.4. Sartorius AG
13.3.5. MGA Technologies
13.3.6. Global Life Sciences Solutions USA LLC (Cytiva)
13.3.7. Vante Biopharm/Sebra
13.3.8. Pall Corporation
13.3.9. Saint-Gobain Performance Plastics
13.3.10. Sentinel Process Systems Inc.
14. Global Sterile Tubing Welder Market 2020-2030
14.1. Market Overview
14.2. By Value (USD Thousand)
14.3. By Volume (Thousand Units)
15. Global Sterile Tubing Welder Market - Segmentation Analysis 2020-2030
15.1. By Application
15.1.1. Component Pooling, 2020-2030F (USD Thousand) and (Thousand Units)
15.1.2. Quality Control Pooling, 2020-2030F (USD Thousand) and (Thousand Units)
15.1.3. Leukoreduction, 2020-2030F (USD Thousand) and (Thousand Units)
15.1.4. Fluid Replacement, 2020-2030F (USD Thousand) and (Thousand Units)
15.1.5. Pathogen Reduction, 2020-2030F (USD Thousand) and (Thousand Units)
15.1.6. Cell Washing & Freezing, 2020-2030F (USD Thousand) and (Thousand Units)
15.1.7. Others, 2020-2030F (USD Thousand) and (Thousand Units)
15.2. By End-User
15.2.1. Hospitals, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.2. Diagnostic Laboratories, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.3. Blood Banks, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.4. Research Organization, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.5. Biopharmaceutical Companies, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.5.1. Cell and Gene Therapies, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.5.2. Recombinant Proteins, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.5.3. Vaccines, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.5.4. Recombinant Enzymes, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.5.5. Synthetic Immunomodulators, 2020-2030F (USD Thousand) and (Thousand Units)
15.2.5.6. Others, 2020-2030F (USD Thousand) and (Thousand Units)
15.3. By Region
15.3.1. North America
15.3.2. Europe
15.3.3. Asia Pacific
15.3.4. Latin America
15.3.5. Middle East & Africa
16. North America Sterile Tubing Welder Market - Segmentation Analysis 2020-2030
16.1. By Application
16.1.1. Component Pooling, 2020-2030F (USD Thousand) and (Thousand Units)
16.1.2. Quality Control Pooling, 2020-2030F (USD Thousand) and (Thousand Units)
16.1.3. Leukoreduction, 2020-2030F (USD Thousand) and (Thousand Units)
16.1.4. Fluid Replacement, 2020-2030F (USD Thousand) and (Thousand Units)
16.1.5. Pathogen Reduction, 2020-2030F (USD Thousand) and (Thousand Units)
16.1.6. Cell Washing & Freezing, 2020-2030F (USD Thousand) and (Thousand Units)
16.1.7. Others, 2020-2030F (USD Thousand) and (Thousand Units)
16.2. By End-User
16.2.1. Hospitals, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.2. Diagnostic Laboratories, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.3. Blood Banks, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.4. Research Organization, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.5. Biopharmaceutical Companies, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.5.1. Cell and Gene Therapies, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.5.2. Recombinant Proteins, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.5.3. Vaccines, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.5.4. Recombinant Enzymes, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.5.5. Synthetic Immunomodulators, 2020-2030F (USD Thousand) and (Thousand Units)
16.2.5.6. Others, 2020-2030F (USD Thousand) and (Thousand Units)
16.3. By Country
16.3.1. United States
16.3.2. Canada
17. Europe Sterile Tubing Welder Market - Segmentation Analysis 2020-2030
17.1. By Application
17.2. By End-User
17.3. By Country
17.3.1. United Kingdom
17.3.2. Germany
17.3.3. Italy
17.3.4. France
17.3.5. Spain
17.3.6. Russia
17.3.7. Netherlands
17.3.8. Rest of Europe
18. Asia Pacific Sterile Tubing Welder Market - Segmentation Analysis 2020-2030
18.1. By Application
18.2. By End-User
18.3. By Country
18.3.1. China
18.3.2. India
18.3.3. Japan
18.3.4. South Korea
18.3.5. Australia
18.3.6. Singapore
18.3.7. Rest of Asia Pacific
19. Latin America Sterile Tubing Welder Market - Segmentation Analysis 2020-2030
19.1. By Application
19.2. By End-User
19.3. By Country
19.3.1. Brazil
19.3.2. Argentina
19.3.3. Mexico
19.3.4. Rest of Latin America
20. Middle East & Africa Sterile Tubing Welder Market - Segmentation Analysis 2020-2030
20.1. By Application
20.2. By End-User
20.3. By Country
20.3.1. GCC
20.3.2. Israel
20.3.3. South Africa
20.3.4. Rest of Middle East & Africa

Companies Mentioned

  • Genesis BPS
  • TERUMO BCT Inc.
  • Wuhan bms Medicaltech Co. Ltd.
  • Sartorius AG
  • MGA Technologies
  • Global Life Sciences Solutions USA LLC (Cytiva)
  • Vante Biopharm/Sebra
  • Pall Corporation
  • Saint-Gobain Performance Plastics
  • Sentinel Process Systems Inc.